|
30 Aug 2025 |
Blue Star
|
Consensus Share Price Target
|
1881.70 |
1860.05 |
- |
-1.15 |
buy
|
|
|
|
|
31 Jan 2021
|
Blue Star
|
Motilal Oswal
|
1881.70
|
680.00
|
802.30
(134.54%)
|
Pre-Bonus/ Split |
Sell
|
|
|
BLSTR's 3QFY21 revenue was 7% below our estimate, with the miss attributable to Electro Mechanical Projects and Services (EMPS) segment. Operating profit stood higher than our estimate on better sales mix and continuation of cost rationalization measures. Net borrowing reduced by INR2.1b to INR1.3b (v/s INR3.4b in 1HFY21 and INR1.3b in 9MFY20). The company continues to maintain higher liquidity in uncertain times as gross debt stood at INR5.9b. The commentary on RAC industry trends suggest improving prospects. We...
|
|
29 Oct 2020
|
Blue Star
|
Dolat Capital
|
1881.70
|
640.00
|
630.90
(198.26%)
|
Target met |
Sell
|
|
|
Q2 was a gradual improvement over Q1 with revenues down 28% YoY, driven by a dip of 16% in the unitary cooling business at Rs3bn. The project business was down 31%, impacted due to sites with sites operating at 65-70% levels in Q2 as they open up. While revenues came in line, EBIDTA and PAT were better than estimates (Exhibit 1) Both the businesses are expected to show improvement as the economy opens up, with company expecting better H2 margins. The AC business is expected to normalize by Q4FY21, which is the next big...
|
|
05 Aug 2020
|
Blue Star
|
Motilal Oswal
|
1881.70
|
460.00
|
506.30
(271.66%)
|
Pre-Bonus/ Split |
Neutral
|
|
|
5 August 2020 successful in reducing its working capital (WC) cycle in FY20. As % of sales, WC stood at 6.2% in F20 (v/s 10.6% in FY19) due to debtor days declining to 57 days in FY20 (v/s 78 days in FY19). Free cash flow (FCF) generated stood at INR3.7b in FY20, implying FCF/EBITDA of 131% and FCF/Adj. PAT of 252%. Over FY14-20, FCF generation stood strong at INR8.9b, implying 100% FCF/Adj. PAT. BLSTRs products are exported to 18 countries across the Middle East, Africa, SAARC and ASEAN regions. Revenues from abroad doubled to INR5.2b in FY20 (v/s INR2.6b in FY15). Also, share of revenue from abroad now constitutes ~10% of the companys total revenue (v/s 8.
|
|
20 Jul 2020
|
Blue Star
|
Dolat Capital
|
1881.70
|
508.00
|
493.30
(281.45%)
|
Target met |
Buy
|
|
|
The Blue Star AR while addressing the covid-19 impact talks about company's focus on constant innovation, product expansion and dealer engagement. The company revamped its products and brand with Virat Kohli as the brand ambassador in FY20. The company has implemented the BlueStar@80 FY24 strategy; management continuity, constant...
|
|
13 May 2020
|
Blue Star
|
Motilal Oswal
|
1881.70
|
450.00
|
469.95
(300.40%)
|
Pre-Bonus/ Split |
Neutral
|
|
|
13 May 2020 Blue Star (BLSTR) barely managed to report profit in 4QFY20 as shutdown toward end-Mar20 impacted the UCP/EMP segments. Also, BLSTR is looking at debt financing to maintain liquidity in the current challenging times. We have cut our FY21E/F22E earnings by 57%/29% as we factor in likely weak primary sales in the UCP segment in FY21 until inventory weak order inflow and execution in the EMP segment as the company focuses on cash conservation. Our SOTP-based TP stands at We continue to prefer Voltas over BLSTR to play the underpenetrated AC market in India. 4QFY20 revenue declined 18.6% YoY to INR13b and was 16% below expectation. Owing to lack of operating leverage and ECL related provisions in the project business, EBITDA declined 66% YoY to INR373m (63% below est.) EBITDA margin was down 400bp YoY to 2.9% (v/s est. Adj. PAT came in at INR96m, down 88% YoY.
|
|
01 Feb 2020
|
Blue Star
|
Way2Wealth
|
1881.70
|
922.00
|
802.80
(134.39%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Blue Star Ltd. (BLUESTAR) reported strong revenue growth of ~13% YoY to `12,359.1mn, with the EMPS segment registering growth of ~16% YoY to `7,588mn driven by strong execution and cost optimisation measures. The UCP segment grew 7.3% YoY/ 11.4% QoQ to...
|
|
18 Nov 2019
|
Blue Star
|
Way2Wealth
|
1881.70
|
878.00
|
798.10
(135.77%)
|
Target met |
Buy
|
|
|
Blue Star Ltd. (BLUESTAR) reported strong revenue growth of 21% YoY to `12,494.7mn, with the EMPS segment registering growth of 24.2% YoY/25.6% QoQ to `7,835.4mn driven by health order book and strong execution. UCP segment grew 10% YoY to `3,772.1mn in line...
|
|
19 Aug 2019
|
Blue Star
|
Way2Wealth
|
1881.70
|
|
709.40
(165.25%)
|
Pre-Bonus/ Split |
Results Update
|
|
|
Blue Star Ltd. (BLUESTAR) reported muted revenue growth of 4.5% YoY to `15,745.5mn, with the UCP segment registering sales growth of 9.2% YoY to `9,068.9mn. EMPS business sales growth was flat for the quarter at `6,239.4mn due to slower pace of execution of orders and preference of being balance-sheet prudent with prompt payment from customers based on order...
|
|
14 Aug 2019
|
Blue Star
|
Reliance Securities
|
1881.70
|
829.00
|
709.90
(165.07%)
|
Target met |
Buy
|
|
|
Blue Star (BLSTR) has reported a muted performance in 1QFY20 with its adjusted PAT growing by 1% YoY to Rs768mn due to muted revenue growth and lower margin across segments. Blended EBITDA margin declined by 184bps YoY to 7.3%. Its revenue grew by 4% YoY to Rs15.8bn led by 9% YoY growth in unitary products segment, while revenue of project business remained flat. Order book rose by 34% YoY to Rs28.4bn, while order inflow grew by 55% YoY to Rs9.7bn. We continue to remain positive on BLSTR on the back of improving margin profile, healthy balance sheet and healthy market share. We maintain our BUY recommendation on the stock with...
|
|
04 Jul 2019
|
Blue Star
|
Way2Wealth
|
1881.70
|
899.00
|
765.70
(145.75%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Strong brand image with growing market share Way2Wealth Brokers Pvt. Ltd. (CIN U67120KA2000PTC027628) SEBI Rgn. No. : INH200002739. No. 14, Frontline Granduer, Walton Road, Bangalore-560001; Website: www.way2wealth.com Email: research@way2wealth.com...
|